Article
Novel sex-biased outcomes in neuroblastoma are associated with distinct gene expression and chromosomal loss patterns
2024-06-17
Abstract excerpt
The worst patient outcomes in neuroblastoma are driven by high-risk disease 1,2 , which is divided into similarly sized MYCN amplified and MYCN non-amplified patient subgroups 3 . Male patients have been reported to have slightly worse outcomes than females in all-patient analyses of multiple studies 3,4 . However, we show here that in MYCN non- amplified high-risk and stage 4s low-risk disease, female patie...
Topics
Open a Topic to create a Post that cites this publication.
- Chromatin Remodeling and Cancer
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Neuroblastoma Research and Treatments
- Neuroendocrine Tumor Research Advances
- Pluripotent Stem Cells Research
- Prostate Cancer Treatment and Research
- Protein Degradation and Inhibitors
- Testicular diseases and treatments
Identifiers and source
- Literature Corpus work
- 1593ef55-5930-5ca2-b442-45bec1b473ae
- DOI
- 10.1101/2024.06.14.599094
